Chau Khuong
Director/Board Member at GALECTO, INC.
Net worth: 905 841 $ as of 2024-05-30
Network origin in Chau Khuong first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 35 | |
| Public Company | Pharmaceuticals: Major | 23 | |
22
| Public Company | Pharmaceuticals: Major | 22 |
| Public Company | Pharmaceuticals: Major | 19 | |
18
| Private Company | Biotechnology | 18 |
| Public Company | Biotechnology | 17 | |
| Public Company | Pharmaceuticals: Major | 17 | |
| Extinct | Pharmaceuticals: Major | 15 | |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark.
13
| Subsidiary | Pharmaceuticals: Major | 13 |
ReViral Ltd.
 ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom.
12
| Subsidiary | Biotechnology | 12 |
Cerapedics, Inc.
 Cerapedics, Inc. Pharmaceuticals: MajorHealth Technology Cerapedics, Inc. engaged in the provision of developing and commercializing novel osteobiologic products. It offers i-FACTOR Bone Graft, an advanced biologic that supported with level I evidence, and provides benefit ratio. The company was founded by Andrew J. Tofe and is headquartered in Westminster, CO.
12
| Holding Company | Pharmaceuticals: Major | 12 |
| Public Company | Medical Specialties | 12 | |
Aerpio Therapeutics, Inc.
 Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Rempex Pharmaceuticals, Inc.
 Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rempex Pharmaceuticals, Inc. develops new therapies to combat the growing issue of antibiotic resistance. It focuses on the discovery and development of new antibacterial drugs to meet the clinical need created by multi-drug resistant bacterial pathogens. The company was founded by Daniel Burgess, Michael Dudley and Jeffery Loutit in June 2011 and is headquartered in San Diego, CA.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
OnCusp Therapeutics6
 OnCusp Therapeutics6 Miscellaneous Commercial ServicesCommercial Services OnCusp Therapeutics is a biotechnology company based in New York, NY and has subsidiaries in China. OnCusp Therapeutics specializes in developing preclinical assets to clinical proof of concept and then partnering out for commercialization in the field of oncology therapeutics. The company is committed to accelerating the advancement of oncology assets by leveraging its deep translational and clinical development expertise. OnCusp Therapeutics is backed by prominent investors including Sequoia Capital, Biotrack Capital, Oriza Seed Capital, and AIHC Capital. The company was founded in 2021 by Andy Fu, Bing Yuan, and Eric Slosberg, with Bing Yuan serving as the CEO since then.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
| Subsidiary | Pharmaceuticals: Major | 3 | |
Perfuse Therapeutics, Inc.
 Perfuse Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Perfuse Therapeutics, Inc. operates as biotechnology company that focuses on retinal perfusion. The company was founded by Sevgi Gurkan in 2018 and is headquartered in San Francisco,CA.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Pieris AG
 Pieris AG BiotechnologyHealth Technology Pieris AG develops and markets Anticalin-brand proteins. The firm specializes in the research and development of its Anticalin technology, with focus on deriving therapeutic proteins from human lipocalins. It focuses on solving pharmacological and pharmaceutical limitations of both protein- and non-protein-based drug platforms. It offers a pipeline of Anticalin therapeutics that has active and multi-program research and development collaborations with biopharmaceutical companies. The company was founded by Arne Skerra, Steffen Schlehuber, and Claus Schalper in 2001 and is headquartered in Freising, Germany.
1
| Extinct | Biotechnology | 1 |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Veritas Medicine, Inc.
 Veritas Medicine, Inc. Internet Software/ServicesTechnology Services Veritas Medicine, Inc. operates an online database of clinical trials. It offers patient enrollment solutions to determine eligibility for upcoming clinical trials. The company was founded by Robert Adelman, Joshua Schultz, and Stephen Knight in 1999 and is headquartered in Cambridge, MA.
1
| Extinct | Internet Software/Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Chau Khuong via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Undergraduate Degree | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Boston University | College/University | Masters Business Admin Masters Business Admin Corporate Officer/Principal Masters Business Admin Undergraduate Degree | |
MPEX Pharmaceuticals, Inc.
 MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services MPEX Pharmaceuticals, Inc. develops and manufactures therapies for antibiotic resistance with focus on gram-negative organisms. It offers Aeroquin (MP- 376), an aerosol formulation of levofloxacin for the treatment of pulmonary infections in patients with cystic fibrosis, as well as antibiotic programs to address antibiotic resistance in gram negative organisms. The company was founded in 2001 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree Undergraduate Degree | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| OBSEVA SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Technical University of Denmark | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Founder Founder | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chairman Director/Board Member | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Masters Business Admin Doctorate Degree Masters Business Admin | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer Director/Board Member | |
| SENTI BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member Founder | |
| San Diego State University | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| INOZYME PHARMA, INC. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| University of California, Davis | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal Chief Investment Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
KCK-US, Inc.
 KCK-US, Inc. Investment ManagersFinance KCK-US, Inc. (KCK-US) is a venture capital subsidiary of KCK Ltd. founded in 2013. The firm is headquartered in New York. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| University of Cambridge | College/University | Undergraduate Degree Masters Business Admin Graduate Degree | |
| NEVRO CORP. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Aerin Medical, Inc.
 Aerin Medical, Inc. Medical SpecialtiesHealth Technology Aerin Medical, Inc. develops non-invasive medical devices. It offers improvement in snoring and nasal airflow during surgery. The company was founded by Scott Jordan Wolf and Andrew G. C. Frazier in 2011 and is headquartered in Sunnyvale, CA. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Human Resources Officer | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree Director/Board Member | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Medtronic Spine LLC
 Medtronic Spine LLC Medical SpecialtiesHealth Technology Medtronic Spine LLC develops medical devices for invasive therapies. It designs, manufactures and markets instruments used in therapies for the restoration of spinal anatomy. The company was founded in 1994 and is headquartered in Minneapolis, MN. | Medical Specialties | Director/Board Member Director/Board Member | |
Novo Seeds
 Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Director of Investments Director of Investments | |
| COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of the Witwatersrand | College/University | Doctorate Degree Doctorate Degree |
Statistics
International
| United States | 37 |
| Denmark | 7 |
| United Kingdom | 4 |
| Israel | 2 |
| Switzerland | 2 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 16 |
| Finance | 7 |
| Commercial Services | 4 |
Operational
| Director/Board Member | 886 |
| Corporate Officer/Principal | 271 |
| Independent Dir/Board Member | 223 |
| Chairman | 132 |
| Chief Executive Officer | 122 |
Most connected contacts
| Insiders | |
|---|---|
| Gunnar Magnus Modee Persson | 51 |
| Michael Powell | 48 |
| Ed Mathers Mathers | 47 |
| Michael Ross | 44 |
| Brian H. Dovey | 40 |
| Søren Lemonius | 39 |
| Peter Barrett | 38 |
| Elaine Jones | 37 |
| Douglas Kohrs | 37 |
| Chen-Ming Yu | 33 |
| Nael Jeremie Richard Kassar | 33 |
| Carl Goldfischer | 31 |
| David Kabakoff | 30 |
| Iain Dukes | 30 |
| Erez Chimovits | 30 |
- Stock Market
- Insiders
- Chau Khuong
- Company connections
